New Republic Capital LLC Purchases 131 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

New Republic Capital LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,900 shares of the healthcare conglomerate’s stock after purchasing an additional 131 shares during the period. New Republic Capital LLC’s holdings in UnitedHealth Group were worth $961,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp grew its position in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares during the period. Geode Capital Management LLC boosted its stake in UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after purchasing an additional 318,039 shares during the last quarter. Franklin Resources Inc. boosted its holdings in shares of UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after acquiring an additional 193,800 shares during the last quarter. International Assets Investment Management LLC lifted its position in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Finally, Fisher Asset Management LLC grew its holdings in shares of UnitedHealth Group by 3.5% in the third quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock worth $1,869,320,000 after acquiring an additional 107,097 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

NYSE UNH opened at $533.17 on Tuesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $490.66 billion, a P/E ratio of 34.40, a P/E/G ratio of 1.45 and a beta of 0.61. The firm’s fifty day simple moving average is $529.18 and its two-hundred day simple moving average is $564.40. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have commented on the company. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Bank of America dropped their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.